Ratings by William Blair (John Kreger)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/25/2022 | Covetrus | CVET | Downgrade | Market Perform (Outperform) |
19.66 (20.69) |
5.24% | Details | |
| 5/10/2022 | SmileDirectClub Inc. | SDC | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/20/2022 | DENTSPLY SIRONA | XRAY | Downgrade | Market Perform (Outperform) |
42.20 (35.87) |
-15% | Details | |
| 11/1/2021 | Science 37 | SNCE | New Coverage | Outperform (N/A) |
9.37 (2.10) |
-77.59% | Details | |
| 8/10/2021 | Stevanato Group S.p.A. | STVN | New Coverage | Outperform (N/A) |
20.00 (15.68) |
-21.6% | Details | |
| 8/10/2021 | SmileDirectClub Inc. | SDC | Downgrade | Market Perform (Outperform) |
6.70 (1.06) |
-84.18% | Details | |
| 4/16/2021 | PPD Inc. | PPD | Downgrade | Market Perform (Outperform) |
43.00 (47.30) |
10% | Details | |
| 6/22/2020 | SmileDirectClub Inc. | SDC | Maintain | Outperform (N/A) |
|
Details | ||
| 5/1/2020 | PRA Health Sciences | PRAH | Downgrade | Market Perform (Outperform) |
98.70 (165.21) |
67.39% | Details | |
| 3/2/2020 | PPD Inc. | PPD | New Coverage | Outperform (N/A) |
27.88 (47.30) |
69.66% | Details | |
| 2/26/2020 | SmileDirectClub Inc. | SDC | Maintain | Outperform (N/A) |
|
Details | ||
| 1/7/2020 | SmileDirectClub Inc. | SDC | Maintain | Outperform (N/A) |
|
Details | ||
| 12/9/2019 | Diplomat Pharmacy | DPLO | Upgrade | Market Perform (Underperform) |
5.81 (4.00) |
-31.15% | Details | |
| 10/7/2019 | SmileDirectClub Inc. | SDC | New Coverage | Outperform (N/A) |
14.72 (1.06) |
-92.8% | Details | |
| 8/7/2019 | Cambrex Corporation | CBM | Downgrade | Market Perform (Outperform) |
40.78 (59.99) |
47.11% | Details | |
| 8/7/2019 | Henry Schein | HSIC | Downgrade | Market Perform (Outperform) |
64.54 (76.02) |
17.79% | Details | |
| 4/23/2019 | West Pharmaceutical | WST | New Coverage | Outperform (N/A) |
111.52 (296.46) |
165.84% | Details | |
| 3/18/2019 | DENTSPLY International | XRAY | Upgrade | Outperform (Market Perform) |
49.19 (42.20) |
-14.21% | Details | |
| 2/22/2019 | Diplomat Pharmacy | DPLO | Downgrade | Underperform (Market Perform) |
13.46 (5.81) |
-56.84% | Details | |
| 2/12/2019 | Covetrus | CVET | New Coverage | Outperform (N/A) |
41.01 (20.69) |
-49.55% | Details | |
| 2/12/2019 | Elanco Animal Health | ELAN | New Coverage | Market Perform (N/A) |
29.69 (20.14) |
-32.17% | Details | |
| 1/24/2019 | Aratana Therapeutics | PETX | Downgrade | Market Perform (Outperform) |
4.37 (4.92) |
12.59% | Details | |
| 1/7/2019 | Diplomat Pharmacy | DPLO | Downgrade | Market Perform (Outperform) |
14.10 (13.46) |
-4.54% | Details | |
| 11/2/2018 | Repligen | RGEN | New Coverage | Outperform (N/A) |
54.22 (165.43) |
205.11% | Details | |
| 10/19/2018 | Syneos | SYNH | Upgrade | Outperform (Market Perform) |
46.60 (71.47) |
53.37% | Details | |
| 9/27/2018 | Henry Schein | HSIC | Maintain | Outperform (N/A) |
|
Details |
